Breast Cancer
Genomic Health Reports Recommendation of Oncotype DX(R) in National Comprehensive Cancer Network Guidelines
Published in Cancer Weekly, January 15th, 2008
Genomic Health, Inc. (NASDAQ:GHDX) reported that the company's Oncotype DX(R) breast cancer assay, used to predict the likelihood of disease recurrence and the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients, has been included in the National Comprehensive Cancer Network (NCCN) 2008 Breast Cancer Treatment Guidelines. Oncotype DX is the only multi-gene expression assay to be recommended by NCCN, an alliance of 21 world-leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. These guidelines were published online at http://www.nccn.org/.
"We are pleased that NCCN, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-01-15)
More Articles from Cancer Weekly
- Cancer
Coronado Initiates Phase I Clinical Trial of Rationally Designed Fourth Generation Doxorubicin Analogue - Cancer Gene Therapy
Study data from G.I. Bauerschmitz et al provide new insights into cancer gene therapy - Cancer Vaccines
New cancer vaccines research from University of Pennsylvania described - Cancer Vaccines
New cancer vaccines research has been reported by scientists at Peking University - Cancer Vaccines
Researchers from Baylor College of Medicine, College of Medicine report on findings in cancer vaccines - Cancer Vaccines
Researchers from University of Pittsburgh detail findings in cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
